Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M F Brady

Showing results (1-10 of 41) with videos related to

Pageof 5
Sort By:
Urology|November 1, 1982
Observations of prolonged use of oral Emcyt in prostatic cancer patientsN H Slack, M F Brady, G P Murphy
American Journal of Clinical Oncology|April 1, 1992
A phase II trial of leuprolide acetate in patients with advanced epithelial ovarian carcinoma. A Gynecologic Oncology Group studyD S Miller, M F Brady, R J Barrett
Cancer|August 1, 1984
A reexamination of the stable category for evaluating response in patients with advanced prostate cancerN H Slack, M F Brady, G P Murphy
The Prostate|January 1, 1984
Stable versus partial response in advanced prostate cancerN H Slack, M F Brady, G P Murphy
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 29, 1999
The Gynecologic Oncology Group experience in ovarian cancerW P McGuire, M F Brady, R F Ozols
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|March 17, 2007
Validation and reduction of FACT/GOG-Ntx subscale for platinum/paclitaxel-induced neurologic symptoms: a gynecologic oncology group studyH Q Huang, M F Brady, D Cella, et al.
Cancer|December 1, 1980
The importance of the stable category for chemotherapy treated patients with advanced and relapsing prostate cancerN H Slack, A Mittelman, M F Brady, et al.
Cancer Research|October 1, 1985
Prognostic factors in patients with advanced stage prostate cancerL J Emrich, R L Priore, G P Murphy, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 29, 1999
Randomised trials in ovarian cancer: trial design considerationsM F Brady, J T Thigpen, J B Vermorken, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 24, 2001
Tamoxifen in the treatment of advanced or recurrent endometrial carcinoma: a Gynecologic Oncology Group studyT Thigpen, M F Brady, H D Homesley, et al.
Pageof 5

Showing results (1-10 of 41) with videos related to

Sort By:
Pageof 5
Urology|November 1, 1982
Observations of prolonged use of oral Emcyt in prostatic cancer patientsN H Slack, M F Brady, G P Murphy
American Journal of Clinical Oncology|April 1, 1992
A phase II trial of leuprolide acetate in patients with advanced epithelial ovarian carcinoma. A Gynecologic Oncology Group studyD S Miller, M F Brady, R J Barrett
Cancer|August 1, 1984
A reexamination of the stable category for evaluating response in patients with advanced prostate cancerN H Slack, M F Brady, G P Murphy
The Prostate|January 1, 1984
Stable versus partial response in advanced prostate cancerN H Slack, M F Brady, G P Murphy
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 29, 1999
The Gynecologic Oncology Group experience in ovarian cancerW P McGuire, M F Brady, R F Ozols
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|March 17, 2007
Validation and reduction of FACT/GOG-Ntx subscale for platinum/paclitaxel-induced neurologic symptoms: a gynecologic oncology group studyH Q Huang, M F Brady, D Cella, et al.
Cancer|December 1, 1980
The importance of the stable category for chemotherapy treated patients with advanced and relapsing prostate cancerN H Slack, A Mittelman, M F Brady, et al.
Cancer Research|October 1, 1985
Prognostic factors in patients with advanced stage prostate cancerL J Emrich, R L Priore, G P Murphy, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 29, 1999
Randomised trials in ovarian cancer: trial design considerationsM F Brady, J T Thigpen, J B Vermorken, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 24, 2001
Tamoxifen in the treatment of advanced or recurrent endometrial carcinoma: a Gynecologic Oncology Group studyT Thigpen, M F Brady, H D Homesley, et al.
Pageof 5